Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hermiston

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|August 1, 1977
The human energy cost of fire fightingP W Lemon, R T Hermiston
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|May 1, 1977
Physiological profile of professional fire fightersP W Lemon, R T Hermiston
Gene Therapy|February 24, 2012
Isolation of more potent oncolytic paramyxovirus by bioselectionR Beier, T Hermiston, D Mumberg
Canadian Journal of Applied Sport Sciences. Journal Canadien Des Sciences Appliquees Au Sport|March 1, 1979
Three hockey skills tests as predictors of hockey playing abilityR T Hermiston, J Gratto, T Teno
Gene Therapy|October 7, 2006
High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotypeI Kuhn, B Larsen, C Gross, et al.
Gene Therapy|May 22, 2009
In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancerM Bauzon, F Jin, P Kretschmer, et al.
Canadian Journal of Applied Sport Sciences. Journal Canadien Des Sciences Appliquees Au Sport|June 1, 1980
Exercise VO2 estimation using recovery samplingP W Lemon, J M Hagberg, R T Hermiston
Journal of Virology|April 5, 2001
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K proteinY Shen, G Kitzes, J A Nye, et al.
Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.
Gene Therapy|June 25, 2004
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirusN K Green, C W Herbert, S J Hale, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|August 1, 1977
The human energy cost of fire fightingP W Lemon, R T Hermiston
Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association|May 1, 1977
Physiological profile of professional fire fightersP W Lemon, R T Hermiston
Gene Therapy|February 24, 2012
Isolation of more potent oncolytic paramyxovirus by bioselectionR Beier, T Hermiston, D Mumberg
Canadian Journal of Applied Sport Sciences. Journal Canadien Des Sciences Appliquees Au Sport|March 1, 1979
Three hockey skills tests as predictors of hockey playing abilityR T Hermiston, J Gratto, T Teno
Gene Therapy|October 7, 2006
High-performance liquid chromatography method for rapid assessment of viral particle number in crude adenoviral lysates of mixed serotypeI Kuhn, B Larsen, C Gross, et al.
Gene Therapy|May 22, 2009
In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancerM Bauzon, F Jin, P Kretschmer, et al.
Canadian Journal of Applied Sport Sciences. Journal Canadien Des Sciences Appliquees Au Sport|June 1, 1980
Exercise VO2 estimation using recovery samplingP W Lemon, J M Hagberg, R T Hermiston
Journal of Virology|April 5, 2001
Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K proteinY Shen, G Kitzes, J A Nye, et al.
Nature Medicine|October 4, 2000
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacyC Heise, T Hermiston, L Johnson, et al.
Gene Therapy|June 25, 2004
Extended plasma circulation time and decreased toxicity of polymer-coated adenovirusN K Green, C W Herbert, S J Hale, et al.
Pageof 2